PALO ALTO, Calif., Oct. 17, 2017 /PRNewswire/ -- Varian (NYSE: VAR)
today announced an 80-year-old male with head & neck cancer
became the first patient in Europe
to be treated on the Halcyon™ system at University
Hospitals Leuven (UZ Leuven) in Belgium. Halcyon is an advanced cancer
treatment system that is more comfortable for the patient while
delivering ease-of-use for healthcare providers, accelerated
installation timeframes, expedited commissioning, simplified
training, and automated treatment.
Halcyon simplifies and enhances virtually every aspect of
image-guided volumetric intensity modulated radiotherapy (IMRT),
and is designed to expand the availability of high-quality cancer
care globally and help save the lives of millions more cancer
patients. It is well suited to handle the majority of cancer
patients, offering advanced treatments for lung, esophagus, brain,
head & neck, and many other forms of cancer.
"We selected the Halcyon system because of its potential to
accelerate the treatment workflow and allow for a much closer
connection between the patient and therapist," said professor Karin
Haustermans, MD, chair of the department, UZ Leuven. "Having now
completed our first treatments I can say that Halcyon lived up to
its promise of a more efficient workflow and better integration of
imaging and treatment, which resulted in a much faster overall
treatment time."
"We are very proud to have partnered with UZ Leuven on making
Halcyon treatments available to patients in Europe just two months after the hospital
ordered this new system," said Kolleen
Kennedy, president of Varian's Oncology Systems business.
"The treatments beginning at UZ Leuven are another important step
in continuing our efforts of advancing cost-effective cancer care
worldwide."
For more information on Halcyon, visit
www.varian.com/halcyon
About Varian Medical Systems
Varian Medical Systems
focuses energy on saving lives and is the world's leading
manufacturer of medical devices and software for treating and
managing cancer. Headquartered in Palo
Alto, California, Varian employs approximately 6,600 people
around the world. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com
View original
content:http://www.prnewswire.com/news-releases/uz-leuven-treats-first-patient-in-europe-on-varian-halcyon-cancer-treatment-system-300537606.html
SOURCE Varian Medical Systems